Novavax to deliver 350 mln COVID-19 vaccine doses to COVAX scheme

  • 📰 Reuters
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Qulity Score:
  • News: 8%
  • Publisher: 97%

Novavax Inc (NVAX.O) said on Thursday it has signed an agreement with the GAVI vaccine alliance to manufacture and distribute 350 million doses of its COVID-19 vaccine candidate to countries participating in the COVAX facility.

United States Headlines News

United States Latest News, United States Headlines

Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed Novavax logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photosaid on Thursday it has signed an agreement with the GAVI vaccine alliance to manufacture and distribute 350 million doses of its COVID-19 vaccine candidate to countries participating in the COVAX facility.

The company said India's Serum Institute will manufacture and deliver the balance of the 1.1 billion doses of its vaccine to be delivered to the COVAX vaccine scheme, under a separate agreement.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Similar News:You can also read news stories similar to this one that we have collected from other news sources.